Moklobemidas

A reversible MAOI which is prescribed to treat depression and anxiety. Its reversibility and short-acting length of effects often means it is used in "pharmahuasca" preparations.

Also known as: Aurorix, Manerix, Aurorex, Ro 11-1163

Classification

Chemical: Medicine
Tag: Pharmaceutical

Effects

Stimulation
Physical Energy
Insomnia
Nausea
Euphoria
Anxiety Suppression
Dizziness
Anxiety
Agitation

Routes of Administration

Oral

Dosage

Common: 300–600 mg/day (divided)
Light: 150–300 mg
Strong: 600–900 mg/day (divided)
Heavy: ≥900 mg/day (divided)
Threshold: 50 mg

Duration

Onset: 0.5-1.5 h
Peak: 1-4 h
Offset: 8-16 h
After Effects: 16-24 h
Total Duration: 8-16 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu